The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1/JNK/p38 MAPK-mediated apoptosis in unilateral ureteral obstruction.
The angiotensin receptor neprilysin inhibitor LCZ696 affords superior cardioprotection and renoprotection compared with renin-angiotensin blockade monotherapy, but the underlying mechanisms remain elusive. Herein, we evaluated whether LCZ696 attenuates renal fibrosis by inhibiting ASK1/JNK/p38 mitog...
Main Authors: | Jun Ding, Sheng Cui, Song Yu Li, Lin Yan Cui, Qi Yan Nan, Xue Jing Lin, Mei Ying Xuan, Jian Jin, Shang Guo Piao, Yu Ji Jiang, Hai Lan Zheng, Ji Zhe Jin, Byung Ha Chung, Chul Woo Yang, Jing Hao Cui, Can Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0286903 |
Similar Items
-
The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats
by: Asadur Rahman, et al.
Published: (2020-03-01) -
LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization
by: Yan Hu, et al.
Published: (2024-12-01) -
The protective effect of LCZ696 in coxsackievirus B3‐induced acute viral myocarditis mice
by: Xu Jing, et al.
Published: (2023-02-01) -
A Meta-Analysis on the Effect and Safety of LCZ696 in the Treatment of Hypertension
by: Li Zheng, et al.
Published: (2021-01-01) -
Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
by: Xiao Juan Liu, et al.
Published: (2020-10-01)